Fundz

Plus Therapeutics reported raising $3 Million in an initial SEC Form D filing, from an offering of $20 Million

PUBLIC · CNSYSep 18, 2026$3M of $20M raised

Amount Raised

$3 Million

$3 Million sold, per SEC Form D (first sale Sep 10, 2026)

Round Type

Post-IPO Equity

HoustonManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalHealth Diagnostics

Who to call at Cerenome, Inc., and when

A new round usually means Cerenome, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cerenome, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cerenome, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cerenome, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cerenome, Inc.

Location

6420 Levit Green Boulevard

Houston, Texas, United States

About

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system with the potential to enhance clinical outcomes for patients. Combining image-guided local beta radiation and targeted drug delivery approaches, the Company is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). The Company has built a supply chain through strategic partnerships that enable the development, manufacturing and future potential commercialization of its products. Plus Therapeutics is led by an experienced and dedicated leadership team and has operations in key cancer clinical development hubs, including Austin and San Antonio, Texas.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cerenome, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsCharles H., Vice President hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Cerenome, Inc.'s next move

See what Strategic adds

Cerenome, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.